Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.29, $0.06 better than the analyst estimate of $0.23. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE